...
首页> 外文期刊>Modern Pathology >MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression
【24h】

MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression

机译:回肠类癌中的microRNA表达:随着肿瘤进展,microRNA-133a的下调

获取原文
           

摘要

MicroRNAs (miRNAs) are involved in cell proliferation, differentiation, and apoptosis and can function as tumor suppressor genes or oncogenes. The role of miRNAs in neuroendocrine tumors such as ileal carcinoids is largely unknown. We examined the differential expression of 95 miRNAs by RT–PCR using the QuantiMir System in eight matching primary and metastatic carcinoid tumors from the ileum. All miRNAs chosen for the QuantiMir System array were based on their potential functions related to cancer biology, cell development, and apoptosis. The expression of miRNAs for the samples was normalized to miRNA-197, and the matching primary and metastatic tumors were compared. There was downregulation of miRNA-133a, -145, -146, -222, and -10b in all samples between the primary and matching metastatic tumors and upregulation of miRNA-183, -488, and -19a+b in six of eight metastatic carcinoids compared to the primary tumors. miRNA-133a was further analyzed by TaqMan real-time RT–PCR and northern hybridization using six additional matching primary and metastatic samples, which supported the PCR array findings. There were significant differences in miRNA-133a expression with downregulation in the metastasis compared to the primary in the eight original cases (PPIn situ hybridization in normal ileum showed that some of the mucosal endocrine cells expressed miRNA-133a. Both primary and metastatic ileal carcinoid tumors expressed miRNA-133a by in situ hybridization. These results provide information about novel marker miRNAs that may be used as biomarkers and/or therapeutic targets in intestinal carcinoid tumors.
机译:MicroRNA(miRNA)参与细胞增殖,分化和凋亡,并可以作为肿瘤抑制基因或癌基因。 miRNA在神经内分泌肿瘤(如回肠类癌)中的作用尚不清楚。我们使用QuantiMir系统通过RT-PCR检测了回肠中8种匹配的原发性和转移性类癌中95种miRNA的差异表达。选择用于QuantiMir系统阵列的所有miRNA均基于其与癌症生物学,细胞发育和细胞凋亡相关的潜在功能。将样本中的miRNA表达标准化为miRNA-197,并比较匹配的原发性和转移性肿瘤。在原发性和匹配转移性肿瘤之间的所有样品中,miRNA-133a,-145,-146,-222和-10b均下调,而在八个转移性肿瘤中的六个中,miRNA-183,-488和-19a + b上调类癌与原发性肿瘤相比。通过TaqMan实时RT-PCR和Northern杂交进一步分析了miRNA-133a,使用了另外六个匹配的主要和转移性样品,这支持了PCR阵列的发现。在八个原始病例中,与原发灶相比,转移中miRNA-133a表达的下调与原发灶有显着差异(正常回肠中的PPIn原位杂交显示,某些粘膜内分泌细胞表达了miRNA-133a。通过原位杂交表达miRNA-133a,这些结果提供了有关新型标记miRNA的信息,这些miRNA可用作肠道类癌中的生物标记和/或治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号